Spiperone Derivatives and Methods of Treating Disorders

Described herein are spiperone derivative compounds which have been found to be useful in methods of stimulating CaCC and treating disorders (or symptoms thereof) associated with CaCC including cystic fibrosis, wherein a compound of the invention is administered to a subject.

Patents:
WO 2,010,039,260

Inventor(s): GUGGINO WILLIAM B [US]; SCHWIEBERT ERIK M [US]; LIANG LIHUA [US]

Type of Offer: Licensing



« More Pharmaceutical Patents

---